Bone marrow as a source of hematopoietic stem cells for human gene therapy of β-thalassemia

Human Gene Therapy

Volumn 22, Issue 4, 2011, Pages 507-513

  Frittoli, Marta Claudia ^a,b   Biral, Erika ^a,b   Cappelli, Barbara ^a,b   Zambelli, Matilde ^a   Roncarolo, Maria Grazia ^a,b,c   Ferrari, Giuliana ^b,c   Ciceri, Fabio ^a   Marktel, Sarah ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIBODY;

ADOLESCENT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BETA THALASSEMIA; BONE MARROW; CELL POPULATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DONOR; ERYTHROID PRECURSOR CELL; FEMALE; GENE THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MULTINUCLEAR CELL; MYELOID PROGENITOR CELL; PATIENT SAFETY; PRESCHOOL CHILD; SCHOOL CHILD; SURGICAL TECHNIQUE;

ADOLESCENT; ANTIGENS, CD34; ANTIGENS, CD45; BETA-THALASSEMIA; BONE MARROW CELLS; CHILD; CHILD, PRESCHOOL; FEMALE; GENE THERAPY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; TRANSPLANTATION, AUTOLOGOUS;

EID: 79954562494     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2010.045     Document Type: Article

References (36)

1. Aiuti, A., Cattaneo, F., Galimberti, S., et al. (2009). Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N. Engl. J. Med. 360, 447-458.
2. Almici, C., Carlo-Stella, C., Wagner, J.E., et al. (1997). Clonogenic capacity and ex vivo expansion potential of umbilical cord blood progenitor cells are not impaired by cryopreservation. Bone Marrow Transplant. 19, 1079-1084. (Pubitemid 27267730)
3. Andreani, M., Testi, M., Battarra, M., et al. (2008). Relationship between mixed chimerism and rejection after bone marrow transplantation in thalassemia. Blood Transfusion 6, 143-149. (Pubitemid 352031647)
4. Attarian, H., Feng, Z., Buckner, C.D., et al. (1996). Long-term cryopreservation of bone marrow for autologous transplantation. Bone Marrow Transplant. 17, 425-430. (Pubitemid 26114504)
5. Bender, J.G., Unverzagt, K.L., Walker, D.E., et al. (1991). Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood 77, 2591-2596.
6. Borgna-Pignatti, C., Cappellini, M.D., De Stefano, P., et al. (2005). Survival and complications in thalassemia. Ann. Acad. Sci. 1054, 40-47. (Pubitemid 43031009)
7. Borgna-Pignatti, C., Rugolotto, S., De Stefano, P., et al. (2004). Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 89, 1187-1193. (Pubitemid 39390442)
8. Canales, M.A., Arrieta, R., Gomez-Rioja, R., et al. (2002). Induction of a hypercoagulability state and endothelial cell activation by granulocyte colony-stimulating factor in peripheral blood stem cell donors. J. Hematother. Stem Cell Res. 11, 675-681. (Pubitemid 34851799)
9. Cartier, N., Hacein-Bey-Abina, S., Bartholomae, C.C., et al. (2009). Hematopoietic stem cell gene therapy with a lentivi-ral vector in X-linked adrenoleukodystrophy. Science 326, 818-823.
10. Cavazzana-Calvo, M., Payen, E., Negre, O., et al. (2010). Transfusion independence and HMGA2 activation after gene therapy of human b-thalassaemia. Nature 467, 318-322.
11. Eldor, A., and Rachmilewitz, E.A. (2002). The hypercoagulable state in thalassemia. Blood 99, 36-43.
12. Falzetti, F., Aversa, F., Minelli, O., et al. (1999). Spontaneous rupture of spleen during peripheral blood stem-cell mobilization in a healthy donor. Lancet 353, 555. (Pubitemid 29078428)
13. Fukuda, T., Okamura, S., Shimoda, K., et al. (1994). Predominance of myeloid antigens in CD34-positive peripheral blood stem cells over those in bone marrow after administration of granulocyte colony-stimulating factor. Eur. J. Hae-matol. 52, 201-206. (Pubitemid 24205472)
14. Hacein-Bey-Abina, S., Hauer, J., Lim, A., et al. (2010). Efficacy of gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 22, 355-364.
15. Halter, J., Kodera, Y., Ispizua, A.U., et al. (2009). Severe events in donors after allogeneic hematopoietic stem cell donation. Haematologica 94, 94-101.
16. Hess, D.A., Bonde, J., Craft, T.P., et al. (2007). Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor. Biol. Blood Marrow Transplant. 13, 398-411. (Pubitemid 46421895)
17. Kao, R.H., Li, C.C., Shaw, C.K., et al. (2009). Correlation between characteristics of unrelated bone marrow donor and cell density of total nucleated cell in bone marrow harvest. Int. J. Hematol. 89, 227-230.
18. Kim, D.H., Jamal, N., Saragosa, R., et al. (2007). Similar outcomes of cryopreserved allogeneic peripheral stem cell transplants (PBSCT) compared with fresh allografts. Biol. Blood Marrow Transplant. 13, 1233-1243. (Pubitemid 47413022)
19. Larochelle, A., Krouse, A., Metzger, M., et al. (2006). AMD3100 mobilizes hematopoietic stem cells with long-term re-populating capacity in nonhuman primates. Blood 107, 3772-3778.
20. LeBlanc, R., Roy, J., Demers, C., et al. (1999). A prospective study of G-CSF effects on hemostasis in allogeneic blood stem cell donors. Bone Marrow Transplant. 23, 991-996. (Pubitemid 29250842)
21. Li, K., Wong, A., Li, C.K., et al. (1999). Granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in b-thalassemia patients: Kinetics of mobilization and composition of apheresis product. Exp. Hematol. 27, 526-532. (Pubitemid 29125062)
22. Lucarelli, G., and Gaziev, J. (2008). Advances in the allogeneic transplantation for thalassemia. Blood Rev. 22, 53-63. (Pubitemid 351282443)
23. Lucarelli, G., Galimberti, M., Polchi, P., et al. (1993). Marrow transplantation in patients with thalassemia responsive to iron chelation therapy. N. Engl. J. Med. 329, 840-844. (Pubitemid 23267211)
24. Miccio, A., Cesari, R., Lotti, F., et al. (2008). In vivo selection of genetically modified erythroblastic progenitors leads to long-term correction of b-thalassemia. Proc. Natl. Acad. Sci. U.S.A. 105, 10547-10552.
25. Miyamoto, T., Shinozuka, T., Maeda, H., et al. (2004). Effect of peripheral blood progenitor cell dose on hematopoietic recovery: Identification of minimal progenitor cell requirements for rapid engraftment. Bone Marrow Transplant. 33, 589-595. (Pubitemid 38455920)
26. Modell, B., and Darlison, M. (2008). Global epidemiology of haemoglobin disorders and derived service indicators. Bull. World Health Org. 86, 480-487. (Pubitemid 351821761)
27. Ott, M.G., Schmidt, M., Schwarzwaelder, K., et al. (2006). Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat. Med. 12, 401-409.
28. Pulsipher, M.A., Nagler, A., Iannone, R., et al. (2006). Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: Ethical and safety considerations for normal pediatric hematopoietic cell donors. Pediatr. Blood Cancer 46, 422-433. (Pubitemid 43334647)
29. Pusic, I., and Dipersio, J.F. (2010). Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells. Curr. Opin. Hematol. 17, 319-326.
30. Roselli, E.A., Mezzadra, R., Frittoli, M.C., et al. (2010). Correction of b-thalassemia major by gene transfer in hemato-poietic progenitors of pediatric patients. EMBO Mol. Med. 2, 315-328.
31. Sadelain, M., Boulad, F., Galanello, R., et al. (2007). Therapeutic options for patients with severe b-thalassemia: The need for globin gene therapy. Hum. Gene Ther. 18, 1-9. (Pubitemid 46105459)
32. Styczynski, J., Elarouci, N., Labopin, M., et al. (2008). Allogeneic sibling donor complications of haematopoietic progenitor cell collection in children: A multi-institutional survey of the PDWP-EBMT Group [abstract 233]. Bone Marrow Transplant. 41, S35.
33. Taher, A.T., Otrock, Z.K., Uthman, I., et al. (2008). Thalassemia and hypercoagulability. Blood Rev. 22, 283-292.
34. Telfer, P. (2009). Update on survival in thalassemia major. Hemoglobin 33(Suppl. 1), S76-S80.
35. Yannaki, E., Papayannopoulou, T., Jonlin, E., et al. (2009a). Safety and efficacy of G-CSF mobilization in major b-thalassemia. Presented at the Ninth Cooley Anemia Symposium, October 21-24, New York, NY.
36. Yannaki, E., Psatha, N., Athanasiou, E., et al. (2009b). Mobilization of hematopoietic stem cells in a thalassemic mouse model: Implications for human gene therapy of thalassemia. Hum. Gene Ther. 21, 299-310.